Dr Marina G Shtern, MD - Medicare Obstetrics & Gynecology in Forest Hills, NY

Dr Marina G Shtern, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Forest Hills, New York. Her current practice location is 107 21 Queens Blvd, Suite 1, Forest Hills, New York. You can reach out to her office (for appointments etc.) via phone at (718) 520-0700.

Dr Marina G Shtern is licensed to practice in New York (license number 212461) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1093870388.

Contact Information

Dr Marina G Shtern, MD
107 21 Queens Blvd, Suite 1,
Forest Hills, NY 11375
(718) 520-0700
(718) 520-7180



Physician's Profile

Full NameDr Marina G Shtern
GenderFemale
SpecialityObstetrics & Gynecology
Location107 21 Queens Blvd, Forest Hills, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1093870388
  • Provider Enumeration Date: 12/27/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 4385638741
  • Enrollment ID: I20040409000397

Medical Identifiers

Medical identifiers for Dr Marina G Shtern such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093870388NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 212461 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Marina G Shtern allows following entities to bill medicare on her behalf.
Entity NameWomen's Choice Obgyn Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780701573
PECOS PAC ID: 6800856709
Enrollment ID: O20041014001087

News Archive

NHS cancer patients' wait to start treatment worrying

Around a fourth of cancer patients under the NHS have a worryingly long wait for their treatment to begin. This is a cause for significant concern say experts.

FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules

Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

By sequencing the entire genomes of tumor cells from six people with a rare cancer of the nose and sinus cavity, Johns Hopkins researchers report they unexpectedly found the same genetic change¾one in a gene involved in muscle formation¾in five of the tumors.

Medicare coverage, pricey cancer drugs and the 'rationing' issue

As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.

DSM Sinochem Pharmaceuticals supports WHO's ‘Call to Action' on antimicrobial resistance

Following the Global Health Summit in Uppsala (Sweden) on 2-3 June, 2015, DSM Sinochem Pharmaceuticals pledged its commitment to the WHO's ‘Call to Action' on antimicrobial resistance issued at the Summit. One of the biggest opportunities to maintain the effectiveness and availability of antibiotics is responsible waste management, to date a highly undervalued dimension in the debate around resistance. DSP promised to use its expertise and influence in this area to help curb antimicrobial resistance.

Read more Medical News

› Verified 6 days ago

Entity NameNew York Queens Medicine And Surgery, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003114851
PECOS PAC ID: 4082883673
Enrollment ID: O20110817000163

News Archive

NHS cancer patients' wait to start treatment worrying

Around a fourth of cancer patients under the NHS have a worryingly long wait for their treatment to begin. This is a cause for significant concern say experts.

FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules

Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

By sequencing the entire genomes of tumor cells from six people with a rare cancer of the nose and sinus cavity, Johns Hopkins researchers report they unexpectedly found the same genetic change¾one in a gene involved in muscle formation¾in five of the tumors.

Medicare coverage, pricey cancer drugs and the 'rationing' issue

As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.

DSM Sinochem Pharmaceuticals supports WHO's ‘Call to Action' on antimicrobial resistance

Following the Global Health Summit in Uppsala (Sweden) on 2-3 June, 2015, DSM Sinochem Pharmaceuticals pledged its commitment to the WHO's ‘Call to Action' on antimicrobial resistance issued at the Summit. One of the biggest opportunities to maintain the effectiveness and availability of antibiotics is responsible waste management, to date a highly undervalued dimension in the debate around resistance. DSP promised to use its expertise and influence in this area to help curb antimicrobial resistance.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Marina G Shtern is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Marina G Shtern, MD
39 Valley View Rd,
Great Neck, NY 11021

Ph: (516) 482-3035
Dr Marina G Shtern, MD
107 21 Queens Blvd, Suite 1,
Forest Hills, NY 11375

Ph: (718) 520-0700

News Archive

NHS cancer patients' wait to start treatment worrying

Around a fourth of cancer patients under the NHS have a worryingly long wait for their treatment to begin. This is a cause for significant concern say experts.

FDA issues Complete Response Letter for approval of Eisai's rabeprazole sodium extended-release capsules

Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

By sequencing the entire genomes of tumor cells from six people with a rare cancer of the nose and sinus cavity, Johns Hopkins researchers report they unexpectedly found the same genetic change¾one in a gene involved in muscle formation¾in five of the tumors.

Medicare coverage, pricey cancer drugs and the 'rationing' issue

As health care costs play an ever-increasing role in Washington's budget drama, Medicare officials announced last week they will continue to pay for two extremely expensive cancer treatments despite lingering questions about their effectiveness. At a cost of about $88,000 per year, the cancer-fighting Avastin will still be available to eligible senior citizens for breast cancer treatment.

DSM Sinochem Pharmaceuticals supports WHO's ‘Call to Action' on antimicrobial resistance

Following the Global Health Summit in Uppsala (Sweden) on 2-3 June, 2015, DSM Sinochem Pharmaceuticals pledged its commitment to the WHO's ‘Call to Action' on antimicrobial resistance issued at the Summit. One of the biggest opportunities to maintain the effectiveness and availability of antibiotics is responsible waste management, to date a highly undervalued dimension in the debate around resistance. DSP promised to use its expertise and influence in this area to help curb antimicrobial resistance.

Read more News

› Verified 6 days ago


Obstetrics & Gynecology Doctors in Forest Hills, NY

Edward Walter Olkowski, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 7010 Austin St, Suite 200, Forest Hills, NY 11375
Phone: 718-268-7337    Fax: 718-268-7377
Irada Shapiro, DO
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 7010 Austin St, Suite 200, Forest Hills, NY 11375
Phone: 718-268-7337    Fax: 718-268-7377
Claudia Ravins,
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 7010 Austin St, Suite 200, Forest Hills, NY 11375
Phone: 718-268-7337    Fax: 718-268-7377
Dr. Barbara A Hessel, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 6915 Yellowstone Blvd, Suite 3, Forest Hills, NY 11375
Phone: 718-275-7200    
Dr. Yakov Levy, M.D.
Obstetrics & Gynecology
Medicare: May Accept Medicare Assignments
Practice Location: 70-31a 108 St. Ste#4, Forest Hills, NY 11375
Phone: 718-520-8700    Fax: 718-520-8050
Meenu Gupta, M.D.
Obstetrics & Gynecology
Medicare: May Accept Medicare Assignments
Practice Location: 10555 62nd Dr, Ste 1h, Forest Hills, NY 11375
Phone: 718-849-2723    Fax: 718-849-3166

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.